Cargando…
Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER(+) breast cancer
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663725/ https://www.ncbi.nlm.nih.gov/pubmed/36376284 http://dx.doi.org/10.1038/s41467-022-34580-3 |
| _version_ | 1784830946595307520 |
|---|---|
| author | Palafox, Marta Monserrat, Laia Bellet, Meritxell Villacampa, Guillermo Gonzalez-Perez, Abel Oliveira, Mafalda Brasó-Maristany, Fara Ibrahimi, Nusaibah Kannan, Srinivasaraghavan Mina, Leonardo Herrera-Abreu, Maria Teresa Òdena, Andreu Sánchez-Guixé, Mònica Capelán, Marta Azaro, Analía Bruna, Alejandra Rodríguez, Olga Guzmán, Marta Grueso, Judit Viaplana, Cristina Hernández, Javier Su, Faye Lin, Kui Clarke, Robert B. Caldas, Carlos Arribas, Joaquín Michiels, Stefan García-Sanz, Alicia Turner, Nicholas C. Prat, Aleix Nuciforo, Paolo Dienstmann, Rodrigo Verma, Chandra S. Lopez-Bigas, Nuria Scaltriti, Maurizio Arnedos, Monica Saura, Cristina Serra, Violeta |
| author_facet | Palafox, Marta Monserrat, Laia Bellet, Meritxell Villacampa, Guillermo Gonzalez-Perez, Abel Oliveira, Mafalda Brasó-Maristany, Fara Ibrahimi, Nusaibah Kannan, Srinivasaraghavan Mina, Leonardo Herrera-Abreu, Maria Teresa Òdena, Andreu Sánchez-Guixé, Mònica Capelán, Marta Azaro, Analía Bruna, Alejandra Rodríguez, Olga Guzmán, Marta Grueso, Judit Viaplana, Cristina Hernández, Javier Su, Faye Lin, Kui Clarke, Robert B. Caldas, Carlos Arribas, Joaquín Michiels, Stefan García-Sanz, Alicia Turner, Nicholas C. Prat, Aleix Nuciforo, Paolo Dienstmann, Rodrigo Verma, Chandra S. Lopez-Bigas, Nuria Scaltriti, Maurizio Arnedos, Monica Saura, Cristina Serra, Violeta |
| author_sort | Palafox, Marta |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9663725 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96637252022-11-15 Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER(+) breast cancer Palafox, Marta Monserrat, Laia Bellet, Meritxell Villacampa, Guillermo Gonzalez-Perez, Abel Oliveira, Mafalda Brasó-Maristany, Fara Ibrahimi, Nusaibah Kannan, Srinivasaraghavan Mina, Leonardo Herrera-Abreu, Maria Teresa Òdena, Andreu Sánchez-Guixé, Mònica Capelán, Marta Azaro, Analía Bruna, Alejandra Rodríguez, Olga Guzmán, Marta Grueso, Judit Viaplana, Cristina Hernández, Javier Su, Faye Lin, Kui Clarke, Robert B. Caldas, Carlos Arribas, Joaquín Michiels, Stefan García-Sanz, Alicia Turner, Nicholas C. Prat, Aleix Nuciforo, Paolo Dienstmann, Rodrigo Verma, Chandra S. Lopez-Bigas, Nuria Scaltriti, Maurizio Arnedos, Monica Saura, Cristina Serra, Violeta Nat Commun Author Correction Nature Publishing Group UK 2022-11-14 /pmc/articles/PMC9663725/ /pubmed/36376284 http://dx.doi.org/10.1038/s41467-022-34580-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Palafox, Marta Monserrat, Laia Bellet, Meritxell Villacampa, Guillermo Gonzalez-Perez, Abel Oliveira, Mafalda Brasó-Maristany, Fara Ibrahimi, Nusaibah Kannan, Srinivasaraghavan Mina, Leonardo Herrera-Abreu, Maria Teresa Òdena, Andreu Sánchez-Guixé, Mònica Capelán, Marta Azaro, Analía Bruna, Alejandra Rodríguez, Olga Guzmán, Marta Grueso, Judit Viaplana, Cristina Hernández, Javier Su, Faye Lin, Kui Clarke, Robert B. Caldas, Carlos Arribas, Joaquín Michiels, Stefan García-Sanz, Alicia Turner, Nicholas C. Prat, Aleix Nuciforo, Paolo Dienstmann, Rodrigo Verma, Chandra S. Lopez-Bigas, Nuria Scaltriti, Maurizio Arnedos, Monica Saura, Cristina Serra, Violeta Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER(+) breast cancer |
| title | Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER(+) breast cancer |
| title_full | Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER(+) breast cancer |
| title_fullStr | Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER(+) breast cancer |
| title_full_unstemmed | Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER(+) breast cancer |
| title_short | Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER(+) breast cancer |
| title_sort | author correction: high p16 expression and heterozygous rb1 loss are biomarkers for cdk4/6 inhibitor resistance in er(+) breast cancer |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663725/ https://www.ncbi.nlm.nih.gov/pubmed/36376284 http://dx.doi.org/10.1038/s41467-022-34580-3 |
| work_keys_str_mv | AT palafoxmarta authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT monserratlaia authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT belletmeritxell authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT villacampaguillermo authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT gonzalezperezabel authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT oliveiramafalda authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT brasomaristanyfara authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT ibrahiminusaibah authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT kannansrinivasaraghavan authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT minaleonardo authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT herreraabreumariateresa authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT odenaandreu authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT sanchezguixemonica authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT capelanmarta authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT azaroanalia authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT brunaalejandra authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT rodriguezolga authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT guzmanmarta authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT gruesojudit authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT viaplanacristina authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT hernandezjavier authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT sufaye authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT linkui authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT clarkerobertb authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT caldascarlos authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT arribasjoaquin authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT michielsstefan authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT garciasanzalicia authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT turnernicholasc authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT prataleix authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT nuciforopaolo authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT dienstmannrodrigo authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT vermachandras authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT lopezbigasnuria authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT scaltritimaurizio authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT arnedosmonica authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT sauracristina authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer AT serravioleta authorcorrectionhighp16expressionandheterozygousrb1lossarebiomarkersforcdk46inhibitorresistanceinerbreastcancer |